QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to its QIAcuity digital PCR (dPCR) ecosystem, with a focus on expanding gene expression capabilities, broadening ...
QIAGEN N.V. QGEN has announced a new partnership with South Korea-based GENCURIX, Inc. to develop oncology assays for use on the QIAcuityDx digital PCR (dPCR) platform. The molecular diagnostics ...
QIAGEN QGEN recently expanded its QIAcuity digital PCR (dPCR) ecosystem with new gene expression solutions, enhanced multiplexing capabilities, workflow automation and standardized analysis tools. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results